首页> 美国卫生研究院文献>Kidney Research and Clinical Practice >Use of fludrocortisone for intradialytic hypotension
【2h】

Use of fludrocortisone for intradialytic hypotension

机译:氟可的松用于透析内低血压的用途

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intradialytic hypotension during dialysis adversely affects a patient’s prognosis and increases mortality. We report a case in which intradialytic hypotension that persisted after the administration of midodrine was relieved after the use of fludrocortisone. Administration of 0.2 mg of fludrocortisone occurred 30 minutes before dialysis. We compared 45 sessions of dialysis without fludrocortisone administration and 45 sessions of dialysis with fludrocortisone administration in one patient. The number of times in which systolic blood pressure became lower than 80 mmHg and the number of early terminations of dialysis due to a decrease in systolic blood pressure were higher in the sessions without fludrocortisone administration than in the sessions with fludrocortisone administration (P < 0.05). Fludrocortisone may be helpful for the treatment of intradialytic hypotension that does not respond to midodrine administration.
机译:透析期间的透析内低血压会对患者的预后产生不利影响,并增加死亡率。我们报告了一个案例,在使用米多君治疗后,透析中持续存在的透析性低血压在使用氟可的松后得到缓解。透析前30分钟服用0.2 mg氟氢可的松。我们比较了一位患者在不使用氟可的松的情况下进行45次透析与在使用氟可的松的情况下进行45次透析的情况。与不给予可的松相比,未给予氟可的松治疗的患者收缩压低于80 mmHg的次数和因收缩压降低导致的透析早期终止的次数要多于氟可的松治疗(P <0.05) 。氟可的松可能有助于治疗对米多君给药无反应的透析内低血压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号